171 related articles for article (PubMed ID: 20530438)
1. Unique SNP in CD44 intron 1 and its role in breast cancer development.
Zhou J; Nagarkatti PS; Zhong Y; Creek K; Zhang J; Nagarkatti M
Anticancer Res; 2010 Apr; 30(4):1263-72. PubMed ID: 20530438
[TBL] [Abstract][Full Text] [Related]
2. Implications of single nucleotide polymorphisms in CD44 exon 2 for risk of breast cancer.
Zhou J; Nagarkatti PS; Zhong Y; Zhang J; Nagarkatti M
Eur J Cancer Prev; 2011 Sep; 20(5):396-402. PubMed ID: 21804359
[TBL] [Abstract][Full Text] [Related]
3. CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population.
Tulsyan S; Agarwal G; Lal P; Agrawal S; Mittal RD; Mittal B
PLoS One; 2013; 8(8):e71073. PubMed ID: 23940692
[TBL] [Abstract][Full Text] [Related]
4. [Association of CD44 polymorphisms with genetic susceptibilities and clinico-pathologic characteristics in breast cancer].
Zhou X; Wu CY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):807-11. PubMed ID: 23387202
[TBL] [Abstract][Full Text] [Related]
5. Association of Single-Nucleotide Polymorphisms of CD44 Gene with Susceptibility to Breast Cancer in Chinese Women.
Lin X; You X; Cao X; Pan S
Med Sci Monit; 2018 May; 24():3077-3083. PubMed ID: 29748526
[TBL] [Abstract][Full Text] [Related]
6. CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.
Jiang L; Deng J; Zhu X; Zheng J; You Y; Li N; Wu H; Lu J; Zhou Y
Breast Cancer Res; 2012 Jul; 14(4):R105. PubMed ID: 22788972
[TBL] [Abstract][Full Text] [Related]
7. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients.
Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858
[TBL] [Abstract][Full Text] [Related]
8. Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand.
Sapcharoen K; Sanguansermsri P; Yasothornsrikul S; Muisuk K; Srikummool M
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2493-2502. PubMed ID: 31450925
[TBL] [Abstract][Full Text] [Related]
9. Unique CD44 intronic SNP is associated with tumor grade in breast cancer: a case control study and in silico analysis.
Esmaeili R; Abdoli N; Yadegari F; Neishaboury M; Farahmand L; Kaviani A; Majidzadeh-A K
Cancer Cell Int; 2018; 18():28. PubMed ID: 29483847
[TBL] [Abstract][Full Text] [Related]
10. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients.
Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M
Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692
[TBL] [Abstract][Full Text] [Related]
11. CD44 increases the efficiency of distant metastasis of breast cancer.
McFarlane S; Coulter JA; Tibbits P; O'Grady A; McFarlane C; Montgomery N; Hill A; McCarthy HO; Young LS; Kay EW; Isacke CM; Waugh DJ
Oncotarget; 2015 May; 6(13):11465-76. PubMed ID: 25888636
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
[TBL] [Abstract][Full Text] [Related]
13. Genetic Variants in CD44 and MAT1A Confer Susceptibility to Acute Skin Reaction in Breast Cancer Patients Undergoing Radiation Therapy.
Mumbrekar KD; Bola Sadashiva SR; Kabekkodu SP; Fernandes DJ; Vadhiraja BM; Suga T; Shoji Y; Nakayama F; Imai T; Satyamoorthy K
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):118-127. PubMed ID: 27816361
[TBL] [Abstract][Full Text] [Related]
14. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
[TBL] [Abstract][Full Text] [Related]
15. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
[TBL] [Abstract][Full Text] [Related]
16. Association of CD44 gene rs187115 polymorphism with colorectal cancer risk and prognosis in Chinese Han population: a case-control study.
Wan Q; Zhang D; Zhou Q; Li M; Wang Y; Song Y; Xu T
Aging (Albany NY); 2019 Nov; 11(21):9616-9625. PubMed ID: 31682231
[TBL] [Abstract][Full Text] [Related]
17. MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.
Paulin FE; O'Neill M; McGregor G; Cassidy A; Ashfield A; Ali CW; Munro AJ; Baker L; Purdie CA; Lane DP; Thompson AM
BMC Cancer; 2008 Oct; 8():281. PubMed ID: 18828900
[TBL] [Abstract][Full Text] [Related]
18.
Li JP; Hsieh MJ; Chou YE; Chao YH; Tsao TC; Yang SF
Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32344833
[TBL] [Abstract][Full Text] [Related]
19. Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis.
Wei W; Hu H; Tan H; Chow LW; Yip AY; Loo WT
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S6. PubMed ID: 23046710
[TBL] [Abstract][Full Text] [Related]
20. Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients.
Mayer S; zur Hausen A; Watermann DO; Stamm S; Jäger M; Gitsch G; Stickeler E
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1229-35. PubMed ID: 18438684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]